SLC9A3 and coronary artery disorder: For example, Huo et al. predicted proteins FGG, SLC9A3, MAPK14, FGF1, FGB, F13A1, and CASR as potential therapeutic targets for the treatment of coronary heart disease (CHD) by combining the centrality-based and differentia-based approaches [30].